| Vision Plus | |
|
2520 James St, Bellingham, WA 98225-3830 | |
| (360) 733-7393 | |
| (360) 722-7785 |
| Full Name | Vision Plus |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2520 James St, Bellingham, Washington |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083827372 | NPI | - | NPPES |
| 2026342 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 3639 (Washington) | Primary |
| Provider Name | Mark D Aginsky |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1730169285 PECOS PAC ID: 0547154882 Enrollment ID: I20040209001089 |
News Archive
NHS England's medical director has warned people against drips being endorsed by celebrities as hangover cures.
The U.S. government doesn't provide a benefit many on Wall Street take for granted and that the European Union, Japan and Russia require.
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.
› Verified 1 days ago
| Provider Name | Daniel C Best |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1811916141 PECOS PAC ID: 7416913082 Enrollment ID: I20041208001048 |
News Archive
NHS England's medical director has warned people against drips being endorsed by celebrities as hangover cures.
The U.S. government doesn't provide a benefit many on Wall Street take for granted and that the European Union, Japan and Russia require.
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.
› Verified 1 days ago
| Provider Name | Mark D Pyle |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1124351796 PECOS PAC ID: 7214075886 Enrollment ID: I20091119000247 |
News Archive
NHS England's medical director has warned people against drips being endorsed by celebrities as hangover cures.
The U.S. government doesn't provide a benefit many on Wall Street take for granted and that the European Union, Japan and Russia require.
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.
› Verified 1 days ago
| Provider Name | John R Mcgiffin |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1538423223 PECOS PAC ID: 7618126541 Enrollment ID: I20121009000240 |
News Archive
NHS England's medical director has warned people against drips being endorsed by celebrities as hangover cures.
The U.S. government doesn't provide a benefit many on Wall Street take for granted and that the European Union, Japan and Russia require.
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.
› Verified 1 days ago
| Provider Name | Dustin Eric Mcgill |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1255765327 PECOS PAC ID: 8123250503 Enrollment ID: I20140417001189 |
News Archive
NHS England's medical director has warned people against drips being endorsed by celebrities as hangover cures.
The U.S. government doesn't provide a benefit many on Wall Street take for granted and that the European Union, Japan and Russia require.
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.
› Verified 1 days ago
| Provider Name | Mark Steven Potomak |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1407370091 PECOS PAC ID: 2365701273 Enrollment ID: I20180123002409 |
News Archive
NHS England's medical director has warned people against drips being endorsed by celebrities as hangover cures.
The U.S. government doesn't provide a benefit many on Wall Street take for granted and that the European Union, Japan and Russia require.
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.
› Verified 1 days ago
| Provider Name | Deborah Gau-wei Wu |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1518489053 PECOS PAC ID: 0042570616 Enrollment ID: I20180131001162 |
News Archive
NHS England's medical director has warned people against drips being endorsed by celebrities as hangover cures.
The U.S. government doesn't provide a benefit many on Wall Street take for granted and that the European Union, Japan and Russia require.
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.
› Verified 1 days ago
| Provider Name | Sepideh P Sabet |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1366907321 PECOS PAC ID: 8224465794 Enrollment ID: I20200221001262 |
News Archive
NHS England's medical director has warned people against drips being endorsed by celebrities as hangover cures.
The U.S. government doesn't provide a benefit many on Wall Street take for granted and that the European Union, Japan and Russia require.
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.
› Verified 1 days ago
| Provider Name | Kyle Gurmej Dosanjh |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1881368041 PECOS PAC ID: 2264837236 Enrollment ID: I20210830001607 |
News Archive
NHS England's medical director has warned people against drips being endorsed by celebrities as hangover cures.
The U.S. government doesn't provide a benefit many on Wall Street take for granted and that the European Union, Japan and Russia require.
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.
› Verified 1 days ago
| Provider Name | Kimberly Ann Paris |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1184297301 PECOS PAC ID: 0143626903 Enrollment ID: I20210902002836 |
News Archive
NHS England's medical director has warned people against drips being endorsed by celebrities as hangover cures.
The U.S. government doesn't provide a benefit many on Wall Street take for granted and that the European Union, Japan and Russia require.
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.
› Verified 1 days ago
| Provider Name | Kelly Christianson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1184303257 PECOS PAC ID: 1658733787 Enrollment ID: I20230821003777 |
News Archive
NHS England's medical director has warned people against drips being endorsed by celebrities as hangover cures.
The U.S. government doesn't provide a benefit many on Wall Street take for granted and that the European Union, Japan and Russia require.
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vision Plus 1225 E Sunset Dr, Suite 125, Bellingham, WA 98226-3597 Ph: (360) 733-7393 | Vision Plus 2520 James St, Bellingham, WA 98225-3830 Ph: (360) 733-7393 |
News Archive
NHS England's medical director has warned people against drips being endorsed by celebrities as hangover cures.
The U.S. government doesn't provide a benefit many on Wall Street take for granted and that the European Union, Japan and Russia require.
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.
› Verified 1 days ago
Dr. Rajbir Kaur Khehra, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4540 Cordata Pkwy Ste 103, Bellingham, WA 98226 Phone: 360-676-8663 Fax: 360-676-8682 | |
Bryan T Redick, OD Optometrist Medicare: Medicare Enrolled Practice Location: 302 36th St, Bellingham, WA 98225 Phone: 360-363-0360 Fax: 360-363-0160 | |
Aleksey Shkurat Od Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 1303 Cornwall Ave, Bellingham, WA 98225 Phone: 360-647-0421 Fax: 360-647-0469 | |
Dr. Cam My Ly, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4125 Arctic Ave, Bellingham, WA 98226 Phone: 360-812-7015 Fax: 360-812-7019 | |
Dr. Hannah Margaret Joyner, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 720 Birchwood Ave, Bellingham, WA 98225 Phone: 360-733-1720 Fax: 360-733-0109 | |
Rhonda Swanson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4420 Meridian St, Kulshan Eye Care, Bellingham, WA 98226 Phone: 360-647-0212 Fax: 360-647-2212 |